Definitive Contract 75N93018C00048
Award Date
9/30/18
Potential Completion Date
7/14/25
Potential Value
$18M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
University Of Montana
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Missoula, MT 59812, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
17
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,172,188 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the University of Montana for a Vaccine Adjuvant Discovery Program. The contract involves research to identify and characterize novel, effective, and safe vaccine adjuvants, including high-throughput screening, mechanism of action studies, lead compound optimization, and in vivo efficacy testing. The...
This federal contract award of $7,924,755.00 was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to the University of Montana for the "DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM". The contract is a definitive, firm fixed-price contract with no set-aside designation. Under this contract, the University of Montana will conduct research and development activities including...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Utah State University. The contract is for biomedical research and development, with a total potential value of $499,999.00. The contract is a definitive contract with a cost-no-fee pricing type, and has an ultimate completion date of August 30, 2011. The contract is not designated as a set-aside. Without additional details...
This is a $7,143,498.00 Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The contract, which does not have a set-aside designation, runs through September 29, 2028. Under this contract, UMB will provide a range of research, education, and clinical services to support NIAID's mission, leveraging the university's...
<p>The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University System of Maryland as the prime contractor. The 7-year contract, valued at $844,451.00, is for "BIOMEDICAL (BASIC)" services and does not have a set-aside designation. The contract was awarded on July 15, 2003, with a completion date of July 13, 2010. The contract type is a Definitive Contract with a Cost No Fee pricing type.</p>
This federal contract award for $18,472,563.99 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Montana. The contract's objective is to identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines. Research under this definitive, cost-no-fee contract will contribute to the pipeline of new adjuvant leads that either exploit the innate immune system or act directly...
This federal contract award, valued at $12,612,049, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for research and development related to infectious disease models, including the provision of small animal models, non-human primate models, animal replacement models, and specialized reagents. This contract is part of a larger $146.3 million...
This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $156,240,393.28, is for "Other Function - Microbial Genome Centers" and does not have a set-aside designation. The contract was awarded on September 15, 2003, with a completion date of December 31, 2009. The contract type is Cost No Fee, indicating the contractor is...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, worth a guaranteed minimum of $50,000.00, was awarded to the University of Massachusetts Medical School (UMass Medical) to provide animal models of infectious diseases research under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery vehicle (IDV). The contract is a firm...
This is a prime contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Arizona, doing business as the Arizona Board of Regents. The $13,812,898.37 contract is for biomedical research services and is not designated as a set-aside award. The University of Arizona is providing a range of specialized research capabilities to NIAID, including expertise in areas such as astrophysics, biomedical...